drugpricingpolicywatch.com - Inflation Reduction Act: Prescription Drug Pricing - Legal Counsel & Litigation | Foley Hoag LLP

Description: Seeking legal counsel regarding Inflation Reduction Act: Prescription Drug Pricing? Foley Hoag Law Firm in Boston, MA represents clients looking for expert counsel and litigation for any legal matters regarding Inflation Reduction Act: Prescription Drug Pricing.

Example domain paragraphs

On June 16, 2021, Governor Jared Polis signed into law SB 21-175 , a law that creates the Colorado Prescription Drug Affordability Review Board (PDAB). The PDAB is required to conduct affordability reviews of certain prescription drugs and determine whether any are unaffordable for Colorado residents. The law authorizes the PDAB to establish Upper Payment Limits (UPLs) for drugs found to be unaffordable, and prohibits all purchases of or payer reimbursements for a drug at an amount that exceeds the UPL esta

In just the last few weeks, Tennessee and Connecticut joined the growing list of states to pass legislation banning the use of accumulator adjustment programs. As my colleague Erik explained earlier this month, manufacturers often provide cost sharing assistance programs to help patients afford certain high-cost specialty drugs. Insurers have in turn implemented “accumulator adjustment programs” that seek to reverse the impact of these programs by not counting the amounts provided by the manufacturer in cal

Three additional states enacted legislation in recent weeks barring the “accumulator adjustment program” cost sharing framework. Accumulator adjustment programs seek to reverse the impact of manufacturer cost sharing assistance for prescription drugs by not counting amounts offset by such assistance toward a patient’s deductible. This can result in high patient out-of-pocket responsibilities after the manufacturer’s cost sharing assistance has been exhausted. For this reason, both drug manufacturers and pat

Links to drugpricingpolicywatch.com (14)